Evidence map›Paper›PMID 23760974›Full record

ReviewCurrent allergy and asthma reports2013

Clinical consequences of targeting IL-17 and TH17 in autoimmune and allergic disorders.

Keven M Robinson, Michelle L Manni, Partha S Biswas, John F Alcorn

Open access · bronzeAbstract readReview
In one paragraph

Review in Current allergy and asthma reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Frontiers in immunology · 2021
    Article
  10. Review
  11. 14-3-3ζ-TRAF5 axis governs interleukin-17A signaling.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  12. Article
  13. Review
  14. Asthma biomarkers in the age of biologics.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2017
    Review
  15. Article
  16. Article
  17. Immunobiology of the critical asthma syndrome.Clinical reviews in allergy & immunology · 2015
    Review
  18. Article
  19. Observational
  20. Differential induction of total IgE by two Salmonella enterica serotypes.Frontiers in cellular and infection microbiology · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Keven M RobinsonDepartment of Pediatrics, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, USA, robinsonkm@upmc.edu.
Michelle L Manni
Partha S Biswas
John F Alcorn
Children's Hospital of Pittsburgh · USUniversity of Pittsburgh Medical Center · US

Funding

Influenza A Inhibits TH17 Host Defense Against Bacterial PneumoniaR01HL107380 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ALCORN, JOHN F · 2012 to 2024
$5.4M
NHLBI NIH HHS R01 HL107380
6 · The paper itself

Abstract

The TH17 lineage of T cells and its canonical cytokine IL-17 have been the focus of many recent studies in autoimmune, allergic, and infectious disease. In this review, we will briefly discuss the current knowledge about the role of these cells and IL-17 in a spectrum of disorders. It is clear that IL-17 plays pathogenic roles in certain conditions while the same pathway is critically important to immunity in others. Targeting of TH17 cells or IL-17 therapeutically may impart many benefits, but this approach is not without potentially serious implications regarding host defense. These issues will be discussed herein as we evaluate pharmacological approaches targeting this pathway that are just beginning to be fully tested in human disease.

Indexed as

AsthmaAutoimmune DiseasesHumansHypersensitivityInterleukin-17Interleukin-23Th17 CellsInterleukin-17Interleukin-23

Identifiers

PMID23760974
PMCPMC3812310
OpenAlexW2090897968

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.